Fukuda Denshi Co., Ltd.
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Major Holders
Updated 2026/01/11| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
MFS Series Trust V-MFS International New Discovery Fund
|
561.0K | 0.00% | |
|
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund
|
432.6K | -0.06% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
206.1K | +0.39% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
136.1K | +3.26% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
100.2K | 0.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.
|
80.1K | -4.64% |
Dividend History 4Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥200 | +5.3% |
| 2024 | ¥190 | +5.6% |
| 2023 | ¥180 | +4.3% |
| 2022 | ¥173 | +15.0% |
| 2021 | ¥150 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥132,098M | ¥134,648M | ¥140,323M | ¥139,007M |
| Gross Profit | ¥67,579M | ¥70,403M | ¥74,447M | ¥73,816M |
| Operating Income | ¥22,709M | ¥24,094M | ¥26,506M | ¥25,874M |
| Pretax Income | ¥23,761M | ¥25,239M | ¥27,020M | ¥27,177M |
| Net Income | ¥16,216M | ¥17,278M | ¥18,693M | ¥18,605M |
| EPS | ¥536.19 | ¥571.25 | ¥622.44 | ¥645.41 |
| Operating Margin | 17.19% | 17.89% | 18.89% | 18.61% |
| Balance Sheet | ||||
| Total Assets | ¥195,495M | ¥206,922M | ¥209,064M | ¥221,321M |
| Total Equity | ¥149,856M | ¥163,047M | ¥169,005M | ¥181,651M |
| Total Liabilities | ¥45,639M | ¥43,875M | ¥40,059M | ¥39,670M |
| Cash | ¥64,057M | ¥67,965M | ¥60,222M | ¥72,374M |
| Interest-bearing Debt | ¥3,822M | ¥3,678M | ¥3,511M | ¥3,317M |
| Equity Ratio | 76.65% | 78.80% | 80.84% | 82.08% |
| D/E Ratio | 0.03 | 0.02 | 0.02 | 0.02 |
| Cash Flow | ||||
| Operating CF | ¥23,111M | ¥23,137M | ¥23,914M | ¥33,019M |
| Investing CF | -¥10,789M | -¥14,210M | -¥14,779M | -¥17,053M |
| Financing CF | -¥4,832M | -¥5,551M | -¥17,066M | -¥5,810M |
| Free CF | ¥8,753M | ¥10,598M | ¥9,791M | ¥20,128M |
| Efficiency | ||||
| ROE | 10.82% | 10.60% | 11.06% | 10.24% |
| ROA | 8.29% | 8.35% | 8.94% | 8.41% |
Latest IR Information
-
No IR information found for this company.
Searched stock code: 6960
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥7,150
Rating Score: - (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Fukuda Denshi Co., Ltd. engages in the manufacture and sale of medical instruments in Japan and internationally. The company offers resting electrocardiograph and stress test products; patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems, such as data management software. Fukuda Denshi Co., Ltd. was founded in 1939 and is based in Tokyo, Japan.